Pharma Journalist -

TraceLink announced that Tubilux has selected TraceLink's serialization solutions to help its 30+ European pharmaceutical manufacturing customers comply with the rapidly approaching…
Read More...

NewLink Genetics announced that it has entered into a clinical collaboration agreement with AstraZeneca to evaluate the combination of indoximod, NewLink Genetics’ small molecule IDO…
Read More...

AstraZeneca has announced positive top-line results of the Phase III, PINNACLE 4 trial in which Bevespi Aerosphere (glycopyrronium and formoterol fumarate 14.4/9.6 µg) demonstrated a…
Read More...

Genelux Corporation, a privately-held biopharmaceutical company focused on the development of its proprietary oncolytic immunotherapy platform, announced that it has treated the first…
Read More...

Janssen-Cilag International NV (Janssen) announced that the European Commission has approved the use of Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide ), a once-daily…
Read More...

Mallinckrodt announced it closed the acquisition of InfaCare Pharmaceutical Corporation, a privately held specialty pharmaceutical company focused on development and commercialization…
Read More...

Medherant has signed an agreement with a Japanese transdermal patch company to evaluate the potential of its TEPI Patch technology to deliver a drug provided by the company.…
Read More...

Amgen and Simcere Pharmaceutical Group announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. The collaboration includes…
Read More...

Teva Pharmaceutical Industries announced the reintroduction of the generic equivalent to Depo-Provera1 Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP)…
Read More...

Gilead Sciences  announced that the China Food and Drug Administration(CFDA) has approved Sovaldi (sofosbuvir 400mg), a once-daily oral nucleotide analog polymerase inhibitor for the…
Read More...